Dry Eye Disease (DED) is a multifactorial condition characterized by a loss of tear film homeostasis, ocular surface inflammation, and symptoms such as burning, grittiness, and blurred vision. Traditionally managed with artificial tears, lid hygiene, and pharmacological interventions, we now recognize that systemic factors—including diet—play a critical role in both the development and management of dry eye. Nutrition can modulate inflammation, affect tear film quality, and influence meibomian gland function. This article explores how omega-3 fatty acids, hydration status, and dietary inflammation contribute to dry eye, and provides evidence-based dietary guidance that eye care professionals can use in practice.

Omega-3 Fatty Acids: Anti-Inflammatory Allies

Mechanisms of Action

Omega-3 fatty acids—particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)—exert potent anti-inflammatory effects. These long-chain polyunsaturated fatty acids integrate into cell membranes, improving membrane fluidity and altering lipid raft composition. In the ocular context, this enhances meibocyte function and lipid layer stability of the tear film.

Furthermore, EPA and DHA are precursors to resolvins and protectins—specialized pro-resolving mediators (SPMs) that actively downregulate inflammation. By competing with arachidonic acid, omega-3s reduce the production of pro-inflammatory eicosanoids such as prostaglandin E2 (PGE2) and leukotriene B4 (LTB4), both of which are elevated in DED.

Clinical Evidence

Multiple randomized controlled trials support the efficacy of omega-3 supplementation in dry eye. The DREAM study (2018), while showing mixed results, did reveal a significant improvement in symptoms in a subset of patients. Other studies have demonstrated increased tear breakup time (TBUT), decreased ocular surface staining, and reduced levels of pro-inflammatory cytokines in tears.

Practical Recommendations

• Daily Intake: Recommend 1,000–2,000 mg of combined EPA and DHA per day.

• Food Sources: Fatty fish (salmon, mackerel, sardines), flaxseed (ALA), chia seeds, walnuts.

• Supplementation: Triglyceride-form fish oil may enhance bioavailability; monitor for gastrointestinal intolerance and bleeding risk in patients on anticoagulants.

Hydration: A Foundational Necessity

Mechanisms of Action

Adequate systemic hydration is vital for maintaining tear volume and osmolarity. Hypohydration increases tear osmolarity, triggering hyperosmolar stress and upregulation of matrix metalloproteinases (MMPs) and inflammatory cytokines on the ocular surface. This cascade accelerates epithelial cell apoptosis and goblet cell loss, worsening dry eye symptoms.

Hydration also supports lacrimal gland secretion and facilitates mucin layer health by preserving conjunctival epithelial integrity.

Clinical Evidence

While less studied than omega-3s, observational data show a strong association between dehydration and DED symptoms. A 2020 cross-sectional study in BMJ Open Ophthalmology found that individuals with lower water intake had significantly higher rates of symptomatic dry eye.

Practical Recommendations

• Water Intake: Encourage patients to consume at least 2–2.5 liters of water daily, adjusted for body weight, activity level, and climate.

• Monitoring: Look for signs of subclinical dehydration in older adults and those on diuretics or antihistamines.

• Tips: Recommend small, frequent sips throughout the day; advise against excessive caffeine and alcohol, which have diuretic effects.

Anti-Inflammatory Foods: Shielding the Ocular Surface

Mechanisms of Action

Chronic, low-grade systemic inflammation can exacerbate ocular surface inflammation and meibomian gland dysfunction. Diets high in antioxidants and phytonutrients can help mitigate this inflammation.

Micronutrients such as vitamins A, C, and E, and trace elements like zinc and selenium, support epithelial health, goblet cell function, and tear film stability. Polyphenols—found in fruits, vegetables, and green tea—modulate nuclear factor kappa B (NF-κB) signaling and reduce inflammatory cytokine production.

Clinical Evidence

A 2019 study in Nutrients found that a Mediterranean-style diet was associated with a lower risk of DED symptoms. Diets high in fruits, vegetables, legumes, and whole grains have been correlated with improved ocular surface parameters and symptom scores.

Practical Recommendations

• Daily Foods:

  • Vitamin A: Sweet potatoes, carrots, kale, liver.

  • Vitamin C: Bell peppers, strawberries, citrus fruits.

  • Polyphenols: Green tea, berries, turmeric, dark chocolate.

  • Zinc & Selenium: Pumpkin seeds, Brazil nuts, lentils, eggs.

• Diet Pattern: Promote a Mediterranean diet model—rich in plant-based foods, lean proteins, and healthy fats.

Foods to Avoid: Minimizing Dietary Triggers

Mechanisms of Harm

Certain dietary components can aggravate ocular surface inflammation. Highly processed foods, refined sugars, and trans fats promote systemic oxidative stress and increase pro-inflammatory mediators such as TNF-α and IL-6. These cytokines disrupt epithelial tight junctions and reduce goblet cell density.

Excess omega-6 fatty acid consumption—especially linoleic acid from vegetable oils—may also tip the eicosanoid balance toward pro-inflammatory prostaglandins and leukotrienes.

Clinical Evidence

While definitive RCTs are limited, epidemiological data suggest that high-glycemic and Western-style diets are associated with worsened dry eye symptoms. Animal models further support the inflammatory role of saturated and trans fats on ocular surface pathology.

Practical Recommendations

• Limit:

  • Processed snacks and baked goods.

  • Fried foods and fast food.

  • Sugar-sweetened beverages.

  • High omega-6 oils (corn, soybean, sunflower).

• Replace with: Whole foods, extra virgin olive oil, and naturally anti-inflammatory ingredients.

Final Thoughts

Dry eye disease is more than an ocular surface problem—it is a systemic condition with multifaceted etiologies. As clinicians, we must expand our treatment paradigms to include nutritional strategies that address the root causes of inflammation and tear film instability. Dietary interventions are non-invasive, cost-effective, and empower patients to take an active role in their care. By recommending omega-3-rich foods, encouraging hydration, emphasizing anti-inflammatory diets, and advising against harmful dietary patterns, we can significantly enhance therapeutic outcomes in dry eye management.

Conclusion

Women over the age of 30 face a distinct combination of hormonal and environmental challenges that predispose them to dry eye disease. With digital device usage continuing to rise, effective, low-maintenance treatments are critical. Nighttime ointments offer significant clinical benefit by restoring tear film integrity during sleep. Among these, EYELIVIO provides a comprehensive solution by combining heat and lubrication to counteract evaporative stress. As frontline eye care providers, optometrists and ophthalmologists must consider integrating nighttime therapy into standard dry eye management protocols, especially for digitally active women in this demographic.

References:

1. Asbell PA, Maguire MG, Peskin E, et al. “Dry Eye Assessment and Management (DREAM) Study.” N Engl J Med. 2018;378(17):1681-1690.
2. Viso E, Rodríguez-Ares MT, Gude F. “Prevalence of and associated factors for dry eye in a Spanish adult population.” Br J Ophthalmol. 2009;93(3):339-344.
3. Kawashima M, et al. “Association between subjective happiness and dry eye disease: A new perspective from the Osaka study.” BMJ Open Ophthalmology. 2020;5:e000471.
4. Galor A, Moein HR, Lee C, et al. “Ocular surface symptoms and inflammation in patients with inflammatory bowel disease.” Ocul Surf. 2020;18(2):322-328.
5. Wolkowitz OM, Reus VI, Mellon SH. “Of sound mind and body: depression, disease, and accelerated aging.” Dialogues Clin Neurosci. 2011;13(1):25-39.
6. Li S, et al. “Dietary Inflammatory Index and Risk of Dry Eye Disease in Women: The Study of Women’s Health Across the Nation (SWAN).” Nutrients. 2022;14(7):1367.
7. Barabino S, Dana R. “Animal models of dry eye: a critical assessment of opportunities and limitations.” Invest Ophthalmol Vis Sci. 2004;45(6):1641-1646.
8. Miljanović B, Trivedi KA, Dana MR, et al. “Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women.” Am J Clin Nutr. 2005;82(4):887-893.
9.